Diabetic neuropathy
Conditions
Interventions
D-psicose is orally administered 3 times a day, 5 g once.
Sponsors
hitomi imachi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: type 2 diabetes patient over 20 years old who have diabetic neuropathy and can not obtain sufficient effect by any of the following treatments (HbA1c 6.5% or more and less than 8.0%) 1) Diet therapy or exercise therapy only 2) Pharmacotherapy in addition to diet therapy / exercise therapy
Exclusion criteria
Exclusion criteria: 1) Patients falling under D-psicose administration contraindications 2) Patients participating in other trials 3) A pregnant woman, a maternity woman, a lactating woman or a woman having a possibility of pregnancy 4) Patients who have poor glycemic control with HbA1c> 8% 5) Patients who have severe renal dysfunction (serum creatinine value> 1.5 mg / dl) 6) Patients with other serious complications 7) Patients judged inappropriate as subjects by other doctor's judgment 8) Patients undergoing drug therapy for diabetic neuropathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in mean value of nerve conduction velocity at the 12th week after administration from the start of administration | — |
Secondary
| Measure | Time frame |
|---|---|
| Conducting physical findings (tendon reflex, vibration sense), laboratory findings (CV - RR), questionnaire survey. | — |
Contacts
Public ContactKensaku Fukunaga
Faculty of Medicine, Kagawa University
Outcome results
None listed